/

Ocugen

Develops gene and cell therapies for rare blindness diseases.

BiotechnologyPharmaceuticals ocugen.com ↗

Company facts

Founded: 2013
Employees: 116
Headquarters: United States
Type: Public
Listed: NASDAQ: OCGN